We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+6.7%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$164B
AUM Growth
+$34B
Cap. Flow
+$21.1B
Cap. Flow %
12.82%
Top 10 Hldgs %
19.02%
Holding
8,908
New
1,440
Increased
3,569
Reduced
2,696
Closed
988

Sector Composition

Rank Sector Weight
1 Technology 6.08%
2 Financials 6.03%
3 Industrials 5.01%
4 Consumer Discretionary 4.73%
5 Healthcare 4.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XLV icon
4401
State Street Health Care Select Sector SPDR ETF
XLV
$44B
$1.07M ﹤0.01%
12,994
-183,149
-93% -$15.1M
AXDX
4402
PUT
DELISTED
Accelerate Diagnostics
AXDX
$1.07M ﹤0.01%
4,090
+1,900
+87% +$445K
GGG icon
4403
CALL
Graco
GGG
$13.5B
$1.07M ﹤0.01%
23,700
+9,300
+65% +$403K
BUFF
4404
CALL
DELISTED
Blue Buffalo Pet Products, Inc
BUFF
$1.07M ﹤0.01%
32,700
+14,100
+76% +$418K
CASH icon
4405
Pathward Financial
CASH
$1.81B
$1.07M ﹤0.01%
+34,620
New +$1M
WAIR
4406
DELISTED
WESCO Aircraft Holdings Inc.
WAIR
$1.07M ﹤0.01%
144,545
+80,979
+127% +$670K
SONC
4407
PUT
DELISTED
Sonic Corp
SONC
$1.07M ﹤0.01%
38,900
+5,600
+17% +$144K
PRDO icon
4408
Perdoceo Education
PRDO
$1.97B
$1.07M ﹤0.01%
88,256
+51,970
+143% +$618K
FISI icon
4409
Financial Institutions
FISI
$814M
$1.06M ﹤0.01%
34,243
-60,377
-64% -$1.9M
SD icon
4410
SandRidge Energy
SD
$533M
$1.06M ﹤0.01%
+50,554
New +$942K
HSII
4411
DELISTED
Heidrick & Struggles
HSII
$1.06M ﹤0.01%
43,345
-6,542
-13% -$153K
MGNX icon
4412
MacroGenics
MGNX
$259M
$1.06M ﹤0.01%
56,029
-29,898
-35% -$558K
TGB
4413
Trekor Metals
TGB
$3.21B
$1.06M ﹤0.01%
455,894
+381,368
+512% +$826K
PTVCB
4414
DELISTED
Protective Insurance Corporation Class B Common Stock
PTVCB
$1.06M ﹤0.01%
44,325
-5,796
-12% -$135K
DCP
4415
PUT
DELISTED
DCP Midstream, LP
DCP
$1.06M ﹤0.01%
29,200
+14,100
+93% +$491K
CPA icon
4416
Copa Holdings
CPA
$5.58B
$1.06M ﹤0.01%
7,904
+5,105
+182% +$664K
FYX icon
4417
First Trust Small Cap Core AlphaDEX Fund
FYX
$1.4B
$1.06M ﹤0.01%
+17,317
New +$1.04M
UNFI icon
4418
PUT
United Natural Foods
UNFI
$2.8B
$1.06M ﹤0.01%
21,500
-9,800
-31% -$428K
ZD icon
4419
PUT
Ziff Davis
ZD
$2B
$1.06M ﹤0.01%
16,215
+5,175
+47% +$337K
WK icon
4420
Workiva
WK
$3.66B
$1.06M ﹤0.01%
49,333
+23,304
+90% +$513K
IPXL
4421
CALL
DELISTED
Impax Laboratories, Inc.
IPXL
$1.06M ﹤0.01%
63,400
+34,700
+121% +$636K
LGND icon
4422
PUT
Ligand Pharmaceuticals
LGND
$5.89B
$1.05M ﹤0.01%
12,343
+2,725
+28% +$236K
TCRT icon
4423
Alaunos Therapeutics
TCRT
$4.84M
$1.05M ﹤0.01%
1,697
+520
+44% +$374K
CXT icon
4424
CALL
Crane NXT
CXT
$2.96B
$1.05M ﹤0.01%
33,972
+22,168
+188% +$648K
FLS icon
4425
PUT
Flowserve
FLS
$10.1B
$1.05M ﹤0.01%
25,000
+11,400
+84% +$477K

Similar funds

Citadel Advisors's Q4 2017 Portfolio in Review

As of Q4 2017, Citadel Advisors held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Citadel Advisors deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.

By sector, the portfolio is most concentrated in Technology at 6.1% of assets, down from 7% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.

  • Citadel Advisors's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
  • Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
  • Citadel Advisors's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
  • Citadel Advisors fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
  • Citadel Advisors's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
  • Citadel Advisors opened 1,440 new positions and closed 988 in Q4 2017.
  • Citadel Advisors's portfolio value rose 26% quarter-over-quarter to $164B.

Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.